RELAPSE
Clinical trials for RELAPSE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE trials appear
Sign up with your email to follow new studies for RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Edited immune cells take on tough lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with relapsed lymphoma tied to the Epstein-Barr virus. The therapy uses the patient's own immune cells, modified to resist a substance tumors use to hide. The goal is to find a safe dose and see if these cells can shrink tum…
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
Gentler myeloma combo aims to help frail patients fight relapse
Disease control OngoingThis study tests a three-drug combination (isatuximab, pomalidomide, and dexamethasone) at lower-than-standard doses in people with multiple myeloma that has returned or not responded to treatment. The goal is to see if the lower doses are both safe and effective for patients who…
Matched conditions: RELAPSE
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Phone Check-Ins could predict eating disorder relapse
Knowledge-focused OngoingThis study follows 250 people who have recovered from an eating disorder to see how often relapses happen and what factors might increase the risk. Participants will get a yearly phone call from a nurse for three years. The goal is to better understand relapse patterns and improv…
Matched conditions: RELAPSE
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC